Literature DB >> 21820586

miR-21 modulates cell apoptosis by targeting multiple genes in renal cell carcinoma.

Aimin Zhang1, Yi Liu, Yizhen Shen, Youhe Xu, Xiangtie Li.   

Abstract

OBJECTIVES: To explore the mechanism of miR-21 involved in the development of renal cell carcinoma.
METHODS: Cell proliferation and apoptosis were measured after repression of miR-21 expression by antisense oligonucleotides. miR-21 targets were scanned using target prediction programs. After reduction of miR-21, Fas ligand and metalloproteinase inhibitor 3 (TIMP3) expression and luciferase activity were detected by Western blot and luciferase reporter assay. The effect of TIMP3 on miR-21-induced cell survival was determined by transfection with TIMP3 lacking 3' untranslated region and miR-21.
RESULTS: The reduction of miR-21 by antisense oligonucleotides inhibited cell proliferation and induced cell apoptosis by activation of caspase pathway in renal cell carcinoma cells. Moreover, bioinformatics analysis revealed that miR-21 has the potential to regulate multiple apoptosis-related genes. The reduction of miR-21 inhibited Fas ligand and TIMP3 expression by targeting the binding site within the 3' untranslated region. Finally, the introduction of TIMP3 cDNA without 3' untranslated region abrogated miR-21-induced cell survival.
CONCLUSIONS: Together, these findings indicate that miR-21 plays a key role in regulating cell apoptosis by targeting multiple genes in renal cell carcinoma.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21820586     DOI: 10.1016/j.urology.2011.03.030

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  19 in total

1.  Local MicroRNA Modulation Using a Novel Anti-miR-21-Eluting Stent Effectively Prevents Experimental In-Stent Restenosis.

Authors:  Dong Wang; Tobias Deuse; Mandy Stubbendorff; Ekaterina Chernogubova; Reinhold G Erben; Suzanne M Eken; Hong Jin; Yuhuang Li; Albert Busch; Christian-H Heeger; Boris Behnisch; Hermann Reichenspurner; Robert C Robbins; Joshua M Spin; Philip S Tsao; Sonja Schrepfer; Lars Maegdefessel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-07-16       Impact factor: 8.311

Review 2.  Nanomedicine Meets microRNA: Current Advances in RNA-Based Nanotherapies for Atherosclerosis.

Authors:  Suresh Gadde; Katey J Rayner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-09       Impact factor: 8.311

Review 3.  Stem Cell-Derived Exosomes, Autophagy, Extracellular Matrix Turnover, and miRNAs in Cardiac Regeneration during Stem Cell Therapy.

Authors:  Priyanka Prathipati; Shyam Sundar Nandi; Paras Kumar Mishra
Journal:  Stem Cell Rev Rep       Date:  2017-02       Impact factor: 5.739

4.  Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression.

Authors:  Gan Yu; Weimin Yao; Kiranmai Gumireddy; Anping Li; Ji Wang; Wei Xiao; Ke Chen; Haibing Xiao; Heng Li; Kun Tang; Zhangqun Ye; Qihong Huang; Hua Xu
Journal:  Mol Cancer Ther       Date:  2014-09-23       Impact factor: 6.261

5.  Up-regulation of microRNA-21 correlates with lower kidney cancer survival.

Authors:  Mohd Saif Zaman; Varahram Shahryari; Guoren Deng; Sobha Thamminana; Sharonjot Saini; Shahana Majid; Inik Chang; Hiroshi Hirata; Koji Ueno; Soichiro Yamamura; Kamaldeep Singh; Yuichiro Tanaka; Z Laura Tabatabai; Rajvir Dahiya
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

6.  Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas.

Authors:  Zofia Wotschofsky; Julia Liep; Hellmuth-Alexander Meyer; Monika Jung; Ina Wagner; Alexander C Disch; Klaus D Schaser; Ingo Melcher; Ergin Kilic; Jonas Busch; Steffen Weikert; Kurt Miller; Andreas Erbersdobler; Hans-Joachim Mollenkopf; Klaus Jung
Journal:  Int J Biol Sci       Date:  2012-10-28       Impact factor: 6.580

7.  Parallel analysis of mRNA and microRNA microarray profiles to explore functional regulatory patterns in polycystic kidney disease: using PKD/Mhm rat model.

Authors:  Harsh Dweep; Carsten Sticht; Asawari Kharkar; Priyanka Pandey; Norbert Gretz
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

8.  Simultaneously expressed miR-424 and miR-381 synergistically suppress the proliferation and survival of renal cancer cells---Cdc2 activity is up-regulated by targeting WEE1.

Authors:  Binghai Chen; Lujing Duan; Guangming Yin; Jing Tan; Xianzhen Jiang
Journal:  Clinics (Sao Paulo)       Date:  2013-06       Impact factor: 2.365

9.  Expression, tissue distribution and function of miR-21 in esophageal squamous cell carcinoma.

Authors:  Nazila Nouraee; Katrien Van Roosbroeck; Mohammad Vasei; Shahriar Semnani; Nader Mansour Samaei; Farshad Naghshvar; Abbas Ali Omidi; George A Calin; Seyed Javad Mowla
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

10.  Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma.

Authors:  Daniel Vergho; Susanne Kneitz; Andreas Rosenwald; Charlotte Scherer; Martin Spahn; Maximilian Burger; Hubertus Riedmiller; Burkhard Kneitz
Journal:  BMC Cancer       Date:  2014-01-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.